AT357700B - Verfahren zur herstellung von neuen in 16- stellung disubstituierten 3-ketosteroiden - Google Patents

Verfahren zur herstellung von neuen in 16- stellung disubstituierten 3-ketosteroiden

Info

Publication number
AT357700B
AT357700B AT191376A AT191376A AT357700B AT 357700 B AT357700 B AT 357700B AT 191376 A AT191376 A AT 191376A AT 191376 A AT191376 A AT 191376A AT 357700 B AT357700 B AT 357700B
Authority
AT
Austria
Prior art keywords
ketosteroids
disubstituted
producing new
producing
new
Prior art date
Application number
AT191376A
Other languages
German (de)
English (en)
Other versions
ATA191376A (de
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Priority to AT398879A priority Critical patent/AT368524B/de
Publication of ATA191376A publication Critical patent/ATA191376A/de
Application granted granted Critical
Publication of AT357700B publication Critical patent/AT357700B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT191376A 1975-03-21 1976-03-16 Verfahren zur herstellung von neuen in 16- stellung disubstituierten 3-ketosteroiden AT357700B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT398879A AT368524B (de) 1975-03-21 1979-05-31 Verfahren zur herstellung von neuen in 16-stellung disubstituierten 3-ketosteroiden

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB11819/75A GB1538227A (en) 1975-03-21 1975-03-21 16,16-disubstituted steroids of the androstene series

Publications (2)

Publication Number Publication Date
ATA191376A ATA191376A (de) 1979-12-15
AT357700B true AT357700B (de) 1980-07-25

Family

ID=9993275

Family Applications (1)

Application Number Title Priority Date Filing Date
AT191376A AT357700B (de) 1975-03-21 1976-03-16 Verfahren zur herstellung von neuen in 16- stellung disubstituierten 3-ketosteroiden

Country Status (15)

Country Link
JP (2) JPS51118756A (fi)
AT (1) AT357700B (fi)
AU (1) AU501246B2 (fi)
BE (1) BE839751A (fi)
CA (1) CA1069498A (fi)
CH (2) CH621560A5 (fi)
DE (1) DE2610497C2 (fi)
DK (1) DK143757C (fi)
FR (2) FR2304345A1 (fi)
GB (1) GB1538227A (fi)
IE (1) IE42308B1 (fi)
IL (2) IL49132A (fi)
NL (1) NL184111C (fi)
SE (2) SE7603410L (fi)
ZA (1) ZA761324B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1602960A (en) * 1977-05-25 1981-11-18 Beecham Group Ltd Process for preparing 16,16-disubstituted steroids of the androstene series
DE2943778A1 (de) * 1979-10-26 1981-05-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17 (alpha) -alkylsteroide, diese enthaltende praeparate sowie verfahren zu ihrer herstellung
DE3514272A1 (de) * 1985-04-17 1986-10-23 Schering AG, 1000 Berlin und 4709 Bergkamen Dermatica
JPS63300153A (ja) * 1987-05-29 1988-12-07 日本碍子株式会社 建築用ほうろうパネル
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
JPH06502161A (ja) * 1990-10-31 1994-03-10 ビーチャム・グループ・パブリック・リミテッド・カンパニー レチノイド浸透作用エンハンサーを含む局所用組成物
GB9205194D0 (en) * 1992-03-10 1992-04-22 Smithkline Beecham Plc Novel composition
WO2003051903A1 (fr) * 2001-12-19 2003-06-26 Chugai Seiyaku Kabushiki Kaisha Derive de l'androstane renfermant un substituant en position 7 et 17
CN108558975B (zh) * 2018-04-26 2021-03-02 昆明理工大学 12β-羟基-雄甾4,14-二烯-16-酮类化合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853926A (en) * 1973-05-29 1974-12-10 Searle & Co 17{62 -hydroxy-16,16-dimethylester-4-en-3-one

Also Published As

Publication number Publication date
FR2304345B1 (fi) 1980-11-07
BE839751A (fr) 1976-09-20
DK123476A (da) 1976-09-22
IL58505A0 (en) 1980-01-31
DK143757B (da) 1981-10-05
NL184111B (nl) 1988-11-16
IE42308B1 (en) 1980-07-16
CA1069498A (en) 1980-01-08
DK143757C (da) 1982-03-22
ZA761324B (en) 1977-02-23
GB1538227A (en) 1979-01-10
DE2610497C2 (de) 1986-10-16
FR2304345A1 (fr) 1976-10-15
FR2445340B1 (fi) 1983-02-11
SE7902256L (sv) 1979-03-13
IL49132A (en) 1980-05-30
DE2610497A1 (de) 1976-10-07
JPS6355488B2 (fi) 1988-11-02
FR2445340A1 (fr) 1980-07-25
NL184111C (nl) 1989-04-17
AU1220776A (en) 1977-09-22
IE42308L (en) 1976-09-21
IL49132A0 (en) 1976-05-31
AU501246B2 (en) 1979-06-14
JPS51118756A (en) 1976-10-18
SE7603410L (sv) 1976-09-22
JPS625920B2 (fi) 1987-02-07
CH631996A5 (en) 1982-09-15
JPS61178920A (ja) 1986-08-11
ATA191376A (de) 1979-12-15
NL7602949A (nl) 1976-09-23
CH621560A5 (en) 1981-02-13

Similar Documents

Publication Publication Date Title
AT344890B (de) Verfahren zur herstellung von neuen 6-thiatetracyclinen
AT344333B (de) Verfahren zur herstellung von neuen 8-thiomethylergolinen
AT360005B (de) Verfahren zur herstellung von neuen sulfonyl- benzimidazolderivaten
AT344896B (de) Verfahren zur herstellung von neuen piperazinyliminorifamycinen
AT362085B (de) Verfahren zur herstellung von neuen 16- -dehydroandrostan-derivaten
AT349633B (de) Verfahren zur herstellung von neuen dauno- saminylanthracylcinonen
AT344163B (de) Verfahren zur herstellung von neuen oxadiazolinon-derivaten
AT350529B (de) Verfahren zur herstellung von neuen acylaminophenylalkylaminen
AT353956B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
ATA585876A (de) Verfahren zur herstellung von neuen 2-benzimidazolylcarbamaten
AT360006B (de) Verfahren zur herstellung von neuen thiazolinylbenzimidazolderivaten
AT343675B (de) Verfahren zur herstellung von neuen biguaniden
ATA428075A (de) Verfahren zur herstellung von neuen 1-aethyl-3a-metasubstituiertes-phenyl-decahydroisochinolinen
AT347453B (de) Verfahren zur herstellung von neuen 5-phenyl- oxazolidinon-2-derivaten
AT357700B (de) Verfahren zur herstellung von neuen in 16- stellung disubstituierten 3-ketosteroiden
AT344150B (de) Verfahren zur herstellung von neuen cyclohexylphenylen
AT342590B (de) Verfahren zur herstellung von neuen 2-amino-6-dialkylaminodihydropyridinen
AT342046B (de) Verfahren zur herstellung von neuen n-benzylaminooxazolinen
AT341539B (de) Verfahren zur herstellung von neuen 3-amino-2beta-thiohydrazoazetidinonen
AT349160B (de) Verfahren zur herstellung von neuen bufatrienolidrhamnosidaethern
AT348697B (de) Verfahren zur herstellung von neuen d- homosteroiden
AT345801B (de) Verfahren zur herstellung von neuen 1-phenoxy- 2-acyloxy-3-amino-propanderivaten
AT347967B (de) Verfahren zur herstellung von neuen biguaniden
AT342617B (de) Verfahren zur herstellung von neuen 1-methyl-3-alkyl-7-oxoalkylxanthinen
ATA460476A (de) Verfahren zur herstellung von neuen monodeuterierten prostaglandinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee